Breaking News, Collaborations & Alliances

Harbour BioMed, Evinova Enter Strategic Collaboration in AI

Will jointly apply AI and digital technologies to enhance the efficiency of innovative biologics development.

Author Image

By: Charlie Sternberg

Associate Editor

Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics, and Evinova, a global health-tech company, have entered a strategic collaboration in artificial intelligence (AI). Under the terms of the collaboration, Harbour BioMed and Evinova China will jointly apply AI and digital technologies to enhance the efficiency of innovative biologics development. Building on their respective strengths, the two companies aim to build an o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters